Vital Images and iCAD form colon CAD (computer-aided detection) deal:

Vital Images is to integrate iCAD's Second Look CT colon computer-aided detection (CAD) application into its flagship imaging software for evaluating CT and MR image data, Vitrea 2. In a non-exclusive deal between the two firms, Minneapolis, Minnesota-based Vital Images will distribute the new CAD option, pending regulatory review from the US FDA. CAD is a software technology designed to identify suspicious areas during CT screening exams, helping physicians find polyps that could lead to colon cancer.

Vital Images is to integrate iCAD's Second Look CT colon computer-aided detection (CAD) application into its flagship imaging software for evaluating CT and MR image data, Vitrea 2. In a non-exclusive deal between the two firms, Minneapolis, Minnesota-based Vital Images will distribute the new CAD option, pending regulatory review from the US FDA. CAD is a software technology designed to identify suspicious areas during CT screening exams, helping physicians find polyps that could lead to colon cancer.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

Execs On The Move: July 7–11, 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

EU Authorities Unite In Call For Urgent Overhaul Of Medtech Regulations

 

EU member states have issued a consensus statement on the urgent need to build momentum to tackle governance and centralization issues as part of much-needed reform of the EU medtech regulatory system.

‘Eyes – A Window Into The Heart’: Retinal AI Tool Predicts Future Risk Of Heart Attack And Stroke

 

A deep-learning AI-based retinal image scanning tool can predict the risk of cardiovascular events over a 10-year period with 70% accuracy. The test is comparable to routine GP health checks, researchers from the University of Dundee have shown.